Placental pathology and long-term neurodevelopment of very preterm infants  by van Vliet, Elvira O.G. et al.
b
s
p
p
u
u
t
Research www.AJOG.org
OBSTETRICS
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of very preterm infants
Elvira O. G. van Vliet, BSc; Jorrit F. de Kieviet, MSc; J. Patrick van der Voorn, MD, PhD;
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f
lOBJECTIVE: The objective of the study was to compare neonatal mor-
bidity and long-term neurodevelopmental outcome between very pre-
term infants with placental underperfusion and very preterm infants
with histological chorioamnionitis.
STUDY DESIGN: We measured the mental and motor development at
age 2 and 7 years in 51 very preterm infants with placental underperfu-
sion and 21 very preterm infants with histological chorioamnionitis.
RESULTS: At 2 years, very preterm infants with placental underperfu-
sion had poorer mental development than very preterm infants with his-
tological chorioamnionitis (mean [SD] 90.8 [18.3] vs 104.1 [17.2], ad-
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doi: 10.1016/j.ajog.2012.03.024justed d  1.12, P  .001). Motor development was not different
etween both groups (92.8 [17.2] vs 96.8 [8.7], adjusted d  0.52,
 .12). At 7 years, large, although nonsignificant, effects were found
or better mental and motor development and fewer behavioral prob-
ems in infants with histological chorioamnionitis.
CONCLUSION: Placental pathology contributes to variance in mental
development at 2 years and should be taken into account when evalu-
ating neurodevelopmental outcome of very preterm infants.
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mNormal placental functioning is ofmajor importance in fetal develop-
ment by its critical role in protection of
the fetus and exchanging nutrients be-
tween mother and child.1 Very preterm
irth (less than 32 weeks of gestation) is
trongly associated with pathology of the
lacenta.1-6 Placental dysfunction ex-
oses the fetus to an unfavorable intra-
terine environment and may contrib-
te to both preterm delivery and damage
o the developing brain.7
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pathology in preterm delivery aremater-
nal vascular underperfusion leading to
fetal hypoxia (placental underperfusion)
and pathology associatedwith acute bac-
terial intrauterine infection (histological
chorioamnionitis).8,9 Other placental le-
sions associated with preterm birth are
chronic villitis, fetal thrombotic vascu-
lopathy, ormassive villous fibrin deposi-
tion.10 The relation between placental un-
erperfusion and preterm birth is possibly
ediated by an interplay between fetal nu-
ritional status, activity of the hypothalamic-
ituitary-adrenal axis and increased
roduction of corticotrophin-releas-
ng hormone, inducing the onset of la-
or.11 In histological chorioamnionitis,
the local release of cytokines possibly
stimulates prostaglandin release by fetal
membranes and uterine deciduas, both
contributing to preterm labor.7,12
Besides contributing to preterm birth,
placental underperfusion and histologi-
cal chorioamnionitis may also directly
affect brain development. Placental un-
derperfusion may lead to fetal hypoxia,
which contributes to the breakdown of
the blood-brain barrier and triggers glu-
tamate excitotoxicity. Free radicals inevelopmental lack
JUNE 2012 Americof antioxidant enzymes in oligodendro-
cytes may further explain the impact of
hypoxia on the premature brain.13 Al-
hough cerebral blood flow increases in
esponse to fetal hypoxia, this brain-
paring effect is probably insufficient to
aintain adequate cerebral oxidative
etabolism.14,15 In histological chorio-
amnionitis, inflammatory cytokinesmay
be neurotoxic and may also increase the
permeability of the blood-brain barrier.
They interfere with normal myelination
of the brain directly by damagingmyelin
and indirectly by causing damage tomy-
elin producing cells.16,17 Cytokines may
also have a systemic effect causing hypo-
tension and disseminated intravascular
coagulation,3 propelling the develop-
ment of brain damage.
Neurodevelopmental outcome in very
preterm infants varies widely. Better pre-
diction of outcome can improve selec-
tionof infants for early therapeutic inter-
ventions.17 Differences in pathological
mechanisms in placental underperfu-
sion and histological chorioamnionitis
may contribute to variation in neonatal
morbidity and outcome. Several studies
have addressed the relationship between
placental pathology and short-termneu-
rodevelopmental outcome in very pre-
an Journal of Obstetrics& Gynecology 489.e1
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Research Obstetrics www.AJOG.orgterm infants.4,18,19 However, studies
oncerning long-term outcome remain
carce.20 Therefore, the differences in out-
comefollowingthese2etiological causesof
preterm delivery remain unclear.
The current study aimed to compare
neonatal morbidity and the short-term
and long-term neurodevelopmental out-
come of very preterm infants with placen-
tal underperfusion and very preterm in-
fants with histological chorioamnionitis.
MATERIALS AND METHODS
Sample
The infants of this study are part of a
larger cohort of a randomized controlled
trial on postnatal glutamine supplemen-
tation in very preterm infants (gesta-
tional age [GA] 32 weeks or birth-
weight [BW]1500 g [range, 24.4–33.3
eeks, n  102]).21 To disentangle the
effect of placental underperfusion and
histological chorioamnionitis, we ex-
cluded infants who had both types of pa-
thology (ie, lesions of placental under-
perfusion and lesions of histological
chorioamnionitis [n  11]). Postnatal
glutamine supplementation did not in-
fluence placenta pathology and did not
influence neurodevelopmental outcome
at 2 years.22 The different types of pla-
cental pathology were equally present in
both treatment groups (data not shown).
The medical ethical review board of our
institute approved the study protocol.
Written informed consent was obtained
from all parents.
Placental histological examination
Placentas were macroscopically exam-
ined and preserved in 10% buffered for-
malin for 24 hours immediately after
delivery.
A minimum of 2 cassettes containing
full-thickness sections from the center of
the normal-appearing placental disk
were taken. Furthermore, sections were
taken from theplacentalmembranes and
the placental and fetal ends of the umbil-
ical cord. Placenta dimensions were ob-
tained and the placentas were weighed
after the removal of the umbilical cord
andmembranes. Themicroscopic exam-
ination was undertaken by an experi-
enced perinatal pathologist (J.P.v.d.V.), a
489.e2 American Journal of Obstetrics& Gynecolowhowas unaware of the clinical outcome
of the infants.
Histologically, placental underperfu-
sion was scored in the presence of char-
acteristics associated with maternal vas-
cular underperfusion as described by
Redline et al23: increased syncytial knots,
villous agglutination, distal villous hyp-
oplasia, and intervillous fibrin. Grade 1
placental underperfusion was scored
when less than 30% of the villous paren-
chyma showed 2 ormore signs of mater-
nal underperfusion, in the presence of no
more than 1 nonmarginal villous infarct.
Grade 2 placental underperfusion was
scored when placental weight was below
the 10th percentile for gestation,24 in the
resence of either 2 or more signs of ma-
ernal underperfusion in greater than
0% of the villous parenchyma, or mul-
iple nonmarginal villous infarcts.
Histological chorioamnionitis was sub-
ivided into a group with only a maternal
esponse and a group with an additional
etal response. A maternal inflammatory
esponse was defined as the presence of
eutrophils in theplacentalmembranes or
he chorionic plate. A fetal inflammatory
esponse was diagnosed when neutrophils
ere present in the umbilical cord vessel
alls or the fetal chorionic plate vessels.
Perinatal characteristics
Perinatal characteristics were recorded
in the initial study.21 In this study, we
nalyzed perinatal characteristics in-
luding maternal age, gravidity, parity,
estational age, BW, BW z-scores, head
ircumference z-scores, Apgar score at 5
inutes, and umbilical cord pH. BW
nd head circumference z-scores were
etermined according to Usher and
cLean.25
Mortality and neonatal morbidity
We assessed the incidence of serious
neonatal infections as previously de-
scribed.21 Furthermore, we assessed the
ccurrence of intraventricular hemor-
hage (IVH), periventricular leukomala-
ia (PVL), Bell stage II or III necrotizing
nterocolitis (NEC),26 retinopathy of
rematurity (ROP),27 bronchopulmo-
ary dysplasia (BPD),28 age at discharge,
nd mortality.
gy JUNE 2012Short-term and long-term
neurodevelopmental outcome
Short-term neurodevelopmental out-
comewas assessed at the corrected age of
2 years by an experienced pediatric psy-
chologist using the Bayley Scales of In-
fant Development II (BSID-II),29 con-
sisting of Mental Development Index
(MDI) and Psychomotor Development
Index (PDI).
At 7 years, 4 subtests of the Wechsler
Intelligence Scale for Children-III
(WISC-III)30 were used to assess perfor-
al IQ (PIQ) and verbal IQ (VIQ). Mo-
or development was measured with the
ovement Assessment Battery for Chil-
ren (MABC),31 evaluatingmanual dex-
erity, ball skills, and balance; higher
cores indicate poorer motor perfor-
ance. Behavioral problems were mea-
ured by the parent-rated Children Be-
avior Checklist32 and the parent-rated
Disruptive BehaviorDisorders question-
naire.33,34 Higher scores indicate poorer
functioning on all subscales.
Statistical analysis
Data were analyzed using analysis of
variance for continuous data and logistic
regression for dichotomous data. Data
that were nonnormally distributed were
corrected using a van der Waerden
transformation.35 Effect size Cohen’s d
were calculated. Cohen’s d is defined by
the difference between 2 means divided
by the pooled SD for those means, and
effect sizes of 0.2, 0.5, and 0.8 are consid-
ered a small, medium, and large effect,
respectively.
The effect of severity of placental pa-
thology (maternal vs fetal histological
chorioamnionitis, grade 1 vs grade 2 pla-
cental underperfusion) was determined
for outcome measures, which were dif-
ferent between infants with histological
chorioamnionitis and infants with pla-
cental underperfusion. To account for
possible bias in selection because of de-
ceased and very disabled infants in our
cohort, we performed additional logistic
regression analysis using a dichotomous
outcome measure, with a cutoff point of
–1 SD, including deceased and severely
disabled infants in the –1 SD group. Sta-
bility of neurodevelopmental outcome
was evaluated by calculating correlations
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www.AJOG.org Obstetrics Researchand the odds ratio between outcome
measurements at 2 and 7 years.
To further clarify the relations be-
tween placental pathology and long-
term neurodevelopment, analyses were
performed with and without adjustment
for possible confounders. Possible con-
founders were defined as factors signifi-
cantly different between both groups
and known to be related to outcome.We
did not adjust for head circumference z-
score because of the high correlation
with BW z-score (r  0.88). Further-
more, we did not adjust for placental
weight because placental weight was part
of our definition of placental underper-
fusion. Therefore, adjusting for placental
weight would remove part of the vari-
ance associated with placental underper-
fusion. Adjustments were made using
linear or logistic regression analysis. To
exclude the possibility that glutamine
supplementation influenced the results,
we tested the interaction effects between
glutamine supplementation, placenta
pathology, and outcome. Data were an-
alyzed using SPSS 17.0 (SPSS Inc, Chi-
cago, IL), and a P  .05 was considered
ignificant.
RESULTS
Subjects
Twenty-one infants with histological
chorioamnionitis and 51 infants with
placental underperfusion were included
in our analysis. There were no significant
interaction effects among glutamine in-
tervention, placental pathology, and
outcome (all P .15).
Perinatal characteristics
Infantswithhistological chorioamnioni-
tis had a lower gestational age than
infants with placental underperfusion
(P .001, d –1.11) but had higher BW
z-scores (d  .79, P  .005) (Table 1).
ead circumference z-score was higher
n infants with histological chorioam-
ionitis than in infants with placental
nderperfusion (d .85, P .003). In-
ants with histological chorioamnionitis
ere less often born with cesarean deliv-
ry (odds ratio [OR], 0.19; 95% confi-
ence interval [CI], 0.06–0.57). Other
erinatal characteristics were not differ-
nt among both groups.Mortality and neonatal morbidity
Incidence of ROP was higher in infants
with histological chorioamnionitis
(29%) than in infants with placental un-
derperfusion (7%) (OR, 5.64; P .03;
95%CI, 1.19–26.83) (Table 2). After ad-
justments forGA, BW z-score, andmode
f delivery, incidence of ROP was not
ifferent between both groups (P.75),
ndicating that the difference in inci-
ence of ROP is largely explained by dif-
erences in these characteristics. The
ncidence of mortality, IVH, sepsis,
neumonia, 1 or more infections, and
PD was not different among both
roups. Due to the low incidence, men-
ngitis (n  0), NEC (n  4), and PVL
(n 4) were not analyzed.
Neurodevelopmental outcome
at age 2 years
At 2 years, 57 infants (79.2%)were avail-
TABLE 1
Perinatal characteristics
Characteristics
Ch
(n
Birthweight, ga 11
...................................................................................................................
Gestational age, da 1
...................................................................................................................
Birthweight z-scorea
...................................................................................................................
Head circumference z-scorea
...................................................................................................................
Male, n (%)
...................................................................................................................
Maternal age, ya
...................................................................................................................
Multiple birth, n (%)
...................................................................................................................
CRIB scorea
...................................................................................................................
Apgar score at 5 min 7, n (%)
...................................................................................................................
Umbilical cord pH 7.10, arterial, n (%)
...................................................................................................................
Cesarean delivery, n (%)
...................................................................................................................
Placental weight, ga,b 2
...................................................................................................................
Preeclampsia, eclampsia, HELLP, n (%)
...................................................................................................................
Clinical abruptio placentae, n (%)
...................................................................................................................
Antenatal corticosteroid, n (%)
...................................................................................................................
Mechanical ventilation, da,c
...................................................................................................................
Age at discharge, da,c
...................................................................................................................
Social economical statusa
...................................................................................................................
CRIB, Clinical Risk Index for Babies; HELLP, hemolysis, elevate
a Data are given as mean SD; b n 16 and n 41; c Exc
van Vliet. Placental pathology and neurodevelopmental oable for follow up (n  43 for placental m
JUNE 2012 Americunderperfusion and n 14 for histolog-
ical chorioamnionitis). Nine infants
(12.5%) were deceased and 6 (8.3%)
were lost to follow-up. Infants with pla-
cental underperfusion had significantly
lowerMDI scores comparedwith infants
with histological chorioamnionitis (d
75, P .02) (Table 3). The difference in
DI scores was small (d .18) and non-
ignificant (P  .59). Adjustment for
estational age, BW z-score, andmode of
elivery did not change the detrimental
ffect of placental underperfusion on
DI scores (d 1.12, P .01).
In the placental underperfusion group
n 43), infants with grade 2 underper-
usion had significantly lower MDI
cores than infants with grade 1 under-
erfusion (84.8 vs 96.6, d .67,P .03).
n the group of infants with histological
horioamnionitis (n  14), MDI scores
id not differ between infants with only
oamnionitis
21)
Placental
underperfusion
(n  51) P value
.7 (317.8) 1111.9 (322.2) .83
..................................................................................................................
.7 (13.3) 206.7 (9.8)  .001
..................................................................................................................
.07 (1.2) –1.12 (1.78) .005
..................................................................................................................
.57 (1.0) –0.45 (1.35) .003
..................................................................................................................
(47.6) 27 (52.9) .68
..................................................................................................................
.1 (6.3) 30.6 (4.7) .29
..................................................................................................................
(14.3) 10 (19.6) .64
..................................................................................................................
.71 (2.9) 3.71 (3.0) .99
..................................................................................................................
(23.8) 15 (29.4) .63
..................................................................................................................
(0) 4 (7.8) .19
..................................................................................................................
(33.0) 37 (72.6) .01
..................................................................................................................
.06 (122.33) 214.98 (86.71) .02
..................................................................................................................
(0) 18 (35.29) .02
..................................................................................................................
(0) 4 (7.8) .19
..................................................................................................................
(76.0) 43 (84.3) .42
..................................................................................................................
.4 (17.8) 9.0 (13.0) .08
..................................................................................................................
.6 (33.4) 67.9 (35.3) .10
..................................................................................................................
.1 (0.8) 3.3 (0.7) .38
..................................................................................................................
er enzymes, and low platelet count.
g deceased infants.
e. Am J Obstet Gynecol 2012.ori
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d 0.91, P .53).
The proportion of infants that perform
less than–1SDwasnotdifferentbetween in-
fantswith placental underperfusion andhis-
tological chorioamnionitis.
Neurodevelopmental outcome
at age 7 years
At 7 years, 49 infants (68.1%) partici-
pated in the follow-up study (n 37 for
placental underperfusion and n 12 for
histological chorioamnionitis). Two in-
fants (2.8%) were not able to participate
because of severe disabilities and 6
(8.3%)were lost to follow-up. At 7 years,
mental and motor development or be-
havioral problems were not different
TABLE 2
Mortality and neonatal morbidity
Outcome measure
Chorio
(n  2
Mortality, n (%) 4 (19
...................................................................................................................
IVH, n (%) 9 (43
...................................................................................................................
Sepsis, n (%) 10 (48
...................................................................................................................
Pneumonia, n (%) 3 (14
...................................................................................................................
1 positive culture, n (%)b 12 (57
...................................................................................................................
ROP, stage 1 or greater, n (%)c 5 (29
...................................................................................................................
BPD, stage 1 or greater, n (%)d 8 (47
...................................................................................................................
BPD, bronchopulmonary dysplasia; IVH, intraventricular hemo
a Adjusted for gestational age, birthweight z-score, cesarea
chorioamnioinitis; n 47 for placental underperfusion.
van Vliet. Placental pathology and neurodevelopmental o
TABLE 3
Neurodevelopmental outcome at ag
Variable
Chorioamnionitis
(n  14)
MDI scoreb 104.1 (17.2)
...................................................................................................................
PDI scoreb 96.8 (8.7)
...................................................................................................................
Chorioamnionit
(n  18)
MDI 85 or deathc 5 (27.7)
...................................................................................................................
PDI 85 or deathc 6 (33.3)
...................................................................................................................
MDI, Mental Development Index; PDI, Psychomotor Developm
a Adjusted for gestational age, birthweight z-score, cesareanvan Vliet. Placental pathology and neurodevelopmental outco
489.e4 American Journal of Obstetrics& Gynecoloamong infants with placental underper-
fusion and infants with histological cho-
rioamnionitis (Table 4). After adjust-
ment for GA, BW z-score, and mode of
delivery, large although nonsignificant ef-
fects were found for intelligence: PIQ (d
0.84,P .18) andVIQ (d 0.88,P .16)
as well as for motor performance: manual
dexterity (d  –1.37, P  .39), ball skills
d–2.69,P .08),andbalance(d–1.24,
 .41). Although neurodevelopmental
outcome was not significantly different, in-
fants with placental underperfusion consis-
tentlyhadlowerscoresthroughoutallneuro-
developmental domains. In further analysis
comparing infants with grade 1 and grade 2
placental underperfusion, only small effect
nionitis
Placental
underperfusion
(n  51) OR
5 (10) 2.20
.........................................................................................................................
12 (24) 2.44
.........................................................................................................................
32 (63) 0.54
.........................................................................................................................
7 (14) 1.05
.........................................................................................................................
35 (69) 0.61
.........................................................................................................................
3 (7) 5.64
.........................................................................................................................
17 (37) 1.57
.........................................................................................................................
e; OR, odds ratio; ROP, retinopathy of prematurity.
livery; b Blood culture or tracheal aspirate; c n  18 for chorio
me. Am J Obstet Gynecol 2012.
2 years
Placental
underperfusion
(n  43) P value C
90.8 (18.3) .02 .7
.........................................................................................................................
92.8 (17.2) .41 .2
.........................................................................................................................
Placental
underperfusion
(n  48) P value
20 (41.6) .30
.........................................................................................................................
16 (33.3) .99
.........................................................................................................................
dex; OR, odds ratio.
ry; b Data are given as mean (SD); c Including deceased and disame. Am J Obstet Gynecol 2012.
gy JUNE 2012sizeswere found (range, 0.10–0.45, data not
shown).
MDI scores at 2 years andWISC scores
at 7 years were significantly correlated
(r  0.61, P  .01). The proportion of
infants performing  -1SD for mental
development was not different at age 2
(MDI) compared to age 7 (WISC, OR,
0.70; 95% CI, 0.33–1.48).
COMMENT
Inourstudy,verypreterminfantswithpla-
cental underperfusion had poorer mental
development at 2 years than very preterm
infantswithhistological chorioamnionitis,
with a difference in mean MDI score of
1.12 SD. The significant difference inMDI
P value
Adjusted
ORa
Adjusted
P valuea
.29 2.35 .41
..................................................................................................................
.11 1.31 .69
..................................................................................................................
.24 0.36 .13
..................................................................................................................
.95 1.09 .94
..................................................................................................................
.35 0.25 .05
..................................................................................................................
.03 1.59 .75
..................................................................................................................
.43 0.65 .66
..................................................................................................................
ionitis; n  47 for placental underperfusion; d n  17 for
n’s d
Adjusted
P valuea Adjusted da
.001 1.12
..................................................................................................................
.12 .52
..................................................................................................................
OR
Adjusted
P valuea
Adjusted
ORa
.54 .19 .32
..................................................................................................................
1.00 .70 .73
..................................................................................................................
infants, data are given as n (%).am
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www.AJOG.org Obstetrics Researchscores between infants with placental un-
derperfusion grade 1 andwith grade 2 fur-
ther suggest that placental underperfusion
is related tomental developmental delay at
2 years of age. At 7 years, large although
nonsignificant adjusted effects were found
for better mental andmotor development
and fewer behavioral problems in infants
with histological chorioamnionitis.
Infants with placental underperfusion
had lower BW, BW z-scores, and head
ircumference z-scores. Impaired growth
s related to reduction of cerebral cortical
ray matter and hippocampal volume,
hich is associated with impaired cogni-
ive functioning.36 This may explain the
oorer mental development of very pre-
erm infants with placental underperfu-
ion inour study.Differences in etiological
athways between the 2 types of placental
athology may further explain the differ-
nce in neurodevelopment. Impaired
rowth in infants with placental under-
erfusion may also reflect that infants
TABLE 4
Neurodevelopmental outcome at ag
Outcome measure
Cho
(n 
Intelligence
..........................................................................................................
WISC-PIQ (SD)b 94
..........................................................................................................
WISC-VIQ (SD)b 106
...................................................................................................................
Motor development
..........................................................................................................
MABC manual dexterity (SD)b 3
..........................................................................................................
MABC ball skills (SD)b 2
..........................................................................................................
MABC balance (SD)b 1
...................................................................................................................
Behavioral problems
..........................................................................................................
CBCL internalizing (SD)b 4
..........................................................................................................
CBCL externalizing (SD)b 5
..........................................................................................................
CBCL attention (SD)b 3
..........................................................................................................
DBD attention (SD)b 5
..........................................................................................................
DBD hyperactivity (SD)b 4
..........................................................................................................
WISC-PIQ 85 or death, n (%)c 8
..........................................................................................................
WISC-VIQ 85 or death, n (%)c 7
..........................................................................................................
MABC 15th % or death, n (%)c 9
...................................................................................................................
CBCL, Children Behavior Checklist, DBD, Disruptive Behavior D
Children–performal IQ; WISC-VIQ, Wechsler Intelligence Scale
a Adjusted for gestational age, birthweight z-score, cesarean
placental underperfusion).
van Vliet. Placental pathology and neurodevelopmental oith placental underperfusion haveeen chronically exposed to an unfa-
orable intrauterine environment. In-
eed, placental underperfusion is de-
cribed as a chronic event, with an onset
ore than 1 week before delivery,
hereas histological chorioamnionitis is
ften a (sub)acute event.37 Besides pre-
natal growth, postnatal growth is also an
important factor for neurodevelopmen-
tal outcome that should be taken into
account.38,39
Although the proportion of infants
with a mental development less than –1
SD did not change over time (ie, mental
developmental disorders do not disap-
pear), there were no significant differ-
ences in mental development between
both groups at 7 years. However, the
large adjusted effect sizes found at 7 years
(d 0.84 for PIQ and d 0.88 for VIQ)
suggest that our samplemay be too small
to detect the effects of placental pathol-
ogy at this age.
No differences in motor development
7 years
amnionitis
2)
Placental
underperfusion
(n  37) P value
.........................................................................................................................
(15.5) 89.2 (16.6) .65
.........................................................................................................................
(18.3) 100.3 (17.6) .59
.........................................................................................................................
.........................................................................................................................
(3.2) 3.8 (4.0) .79
.........................................................................................................................
(2.2) 3.9 (2.7) .21
.........................................................................................................................
(2.4) 2.5 (3.9) .49
.........................................................................................................................
.........................................................................................................................
(3.5) 4.7 (4.4) .98
.........................................................................................................................
(3.8) 6.4 (6.1) .58
.........................................................................................................................
(2.5) 4.2 (3.1) .64
.........................................................................................................................
(4.9) 4.8 (3.8) .49
.........................................................................................................................
(5.1) 4.6 (3.5) .95
.........................................................................................................................
0.0) 12 (27.3) .10
.........................................................................................................................
3.8) 14 (31.8) .39
.........................................................................................................................
6.3) 25 (56.8) .97
.........................................................................................................................
ers questionnaire;MABC,Movement Assessment Battery for Chil
Children–verbal IQ.
ery; b Data are given as mean  SD; c Including deceased and s
me. Am J Obstet Gynecol 2012.were found at the age of 2 years. This
JUNE 2012 Americseems to indicate that placental pathol-
ogy does not interferewith attainingmo-
tor milestones as measured with BSID-
II. At 7 years, we found no significant
differences in motor performance or be-
havioral problems. However, large effect
sizes (d ranging from 1.24 to 2.69) for
motor performance, after correction for
possible confounders, also suggest that
our sample size might have been too
small to detect these differences.
The lower GA in infants with histolog-
ical chorioamnionitis comparedwith in-
fants with placental underperfusion is in
accordance with previous studies.5,18 In
our study, infants with histological cho-
rioamnionitis had a 5 times higher risk of
developing ROP, but after adjustment
for baseline differences in GA, BW
z-score, and mode of delivery, the inci-
dence of ROPwas not different. A recent
study of Dammann et al40 provided pre-
liminary evidence for a multihit sce-
Effect
size
d, OR
Adjusted
P valuea
Adjusted effect
size d, ORa
..................................................................................................................
0.31 .18 0.84
..................................................................................................................
0.36 .16 0.88
..................................................................................................................
..................................................................................................................
–0.08 .39 –1.37
..................................................................................................................
–0.45 .08 –2.69
..................................................................................................................
–0.25 .41 –1.24
..................................................................................................................
..................................................................................................................
0.00 .65 0.63
..................................................................................................................
–0.20 .78 –0.09
..................................................................................................................
–0.18 .32 –1.39
..................................................................................................................
0.23 .76 –0.48
..................................................................................................................
0.03 .72 –0.58
..................................................................................................................
2.67 .29 2.48
..................................................................................................................
1.67 .84 1.18
..................................................................................................................
0.98 .66 0.69
..................................................................................................................
OR, odds ratio;WISC-PIQ, Wechsler Intelligence Scale for
ly disabled infants (n  16 for chorioamnionitis; n  44 fore
rio
1
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.2
......... .........
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......... .........
......... .........
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......... .........
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......... .........
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......... .........
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......... .........
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......... .........
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......... .........
(5
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......... .........
isord dren;
for
deliv everenario, in which the effect of chorioam-
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Research Obstetrics www.AJOG.orgnionitis appears to be overwhelmed by
the effect of GA. The results of our study
support this hypothesis.
Our study has some limitations that
need to be considered. First, the number
of infants with placental underperfusion
may be an overrepresentation of the in-
cidence in the general very preterm pop-
ulation because this study was con-
ducted in a university medical center
specializing in preeclampsia, which is as-
sociated with placental underperfusion.
Multicenter cohort studies would pro-
vide more evidence for the relation be-
tween placental pathology and neonatal
outcome.
Second, the sample size of this study
was rather small. Large but nonsignifi-
cant effect sizes in our analysis indicate
that our statistical tests lacked power to
detect these effects. Larger samples
would also provide the opportunity to
further study the impact of severity of the
various placental lesions, helping to fur-
ther disentangle the etiology of neurode-
velopmental impairments in very pre-
term infants. Studies on outcome in very
preterm infants have a relatively high
proportion of nonsurviving infants or
infants who were too disabled to be
tested, thereby interferingwith outcome.
In this study, we also performed anal-
yses on dichotomous outcomemeasures
including nonsurviving infants and very
disabled infants. In general, these analy-
ses showed similar results. Furthermore,
we focused only on microscopic charac-
teristics of placental dysfunction. Mac-
roscopic abnormalities of the placenta
and umbilical cord may also be associ-
ated with outcome. For example, hyper-
coiling of the umbilical cord is associated
with histological signs of fetal hypoxia
and intrauterine mortality in term in-
fants,41 but the role of umbilical cord
oiling in preterm infants remains un-
lear. Comprehensive studies assessing
acroscopic, histological, and imaging
ata on placental functioning may eluci-
ate the role of placental functioning in
hese vulnerable infants.
In conclusion, our study provides evi-
ence that placental pathology contrib-
tes to the variance in neonatal character-
stics and short-termneurodevelopmental
489.e6 American Journal of Obstetrics& Gynecoloutcome in verypreterm infants. Placental
athology should be taken into account
hen evaluating neurodevelopmental out-
omeof very preterm infants. f
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